| Intramolecular Friedel–Crafts acylation reaction promoted by 1, 1, 1, 3, 3, 3-hexafluoro-2-propanol HF Motiwala, RH Vekariya, J Aube Organic letters 17 (21), 5484-5487, 2015 | 147 | 2015 |
| Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts,” produce opposite effects at the human dopamine transporter K Cameron, R Kolanos, R Verkariya, L De Felice, RA Glennon Psychopharmacology 227, 493-499, 2013 | 127 | 2013 |
| Hexafluoro-2-propanol-promoted intermolecular Friedel–Crafts acylation reaction RH Vekariya, J Aube Organic letters 18 (15), 3534-3537, 2016 | 117 | 2016 |
| A concomitant allylic azide rearrangement/intramolecular azide–alkyne cycloaddition sequence RH Vekariya, R Liu, J Aubé Organic letters 16 (7), 1844-1847, 2014 | 53 | 2014 |
| A novel mu-delta opioid agonist demonstrates enhanced efficacy with reduced tolerance and dependence in mouse neuropathic pain models W Lei, RH Vekariya, S Ananthan, JM Streicher The journal of pain 21 (1-2), 146-160, 2020 | 41 | 2020 |
| Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats BA Hutsell, MH Baumann, JS Partilla, ML Banks, R Vekariya, RA Glennon, ... European Neuropsychopharmacology 26 (2), 288-297, 2016 | 26 | 2016 |
| Synthesis and Structure–Activity Relationships of 5′-Aryl-14-alkoxypyridomorphinans: Identification of a μ Opioid Receptor Agonist/δ Opioid Receptor Antagonist Ligand with … RH Vekariya, W Lei, A Ray, SK Saini, S Zhang, G Molnar, D Barlow, ... Journal of medicinal chemistry 63 (14), 7663-7694, 2020 | 24 | 2020 |
| Targeting the HuR oncogenic role with a new class of cytoplasmic dimerization inhibitors N Filippova, X Yang, S Ananthan, J Calano, V Pathak, L Bratton, ... Cancer research 81 (8), 2220-2233, 2021 | 22 | 2021 |
| Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor LS Chun, RH Vekariya, RB Free, Y Li, DT Lin, P Su, F Liu, Y Namkung, ... Frontiers in synaptic neuroscience 10, 2, 2018 | 16 | 2018 |
| Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists J Younkin, SA Gaitonde, A Ellaithy, R Vekariya, L Baki, JL Moreno, ... ACS chemical neuroscience 7 (9), 1292-1299, 2016 | 13 | 2016 |
| SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 … J Zhu, PM Quizon, Y Wang, CA Adeniran, MJ Strauss, AC Jiménez-Torres, ... Neuropharmacology 220, 109239, 2022 | 7 | 2022 |
| Towards understanding the mechanism of action of abused cathinones R Vekariya | 2 | 2012 |
| Hexafluoro‐2‐propanol‐promoted Intramolecular Friedel‐Crafts Acylation RH Vekariya, MC Horton, J Aubé* Organic Syntheses 95, 486-499, 2018 | 1 | 2018 |
| Selective PLK4 Inhibitors Demonstrate Synthetic Lethality in TRIM37 Amplified Neuroblastoma and Breast Cancer Models While Less Selective Inhibitors Do Not SK McRee, X Chen, C Colas, A Daemen, W Fang, W Kong, J Long, F Liu, ... | | 2023 |
| Studies and Synthetic Methodology: 1. Cycloaddition of Allylic Azides and Alkynes, 2. Hexafluoro-2-propanol-promoted Friedel–Crafts Acylation Reactions RH Vekariya University of Kansas, 2016 | | 2016 |
| Friedel-Crafts chemistry in HFIP R Vekariya, H Motiwala, S Roy, M Bovino, J Aube ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | | 2016 |
| Development of Structure‐Activity Relationships for a G protein‐Biased Agonist of the D2 Dopamine Receptor LS Chun, RB Free, RH Vekariya, T Beuming, L Shi, J Aubé, K Frankowski, ... The FASEB Journal 29, 772.2, 2015 | | 2015 |
| Combined allylic azide rearrangement/intramolecular azide-alkyne cycloaddition reaction RH Vekariya, R Liu, J Aube ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 248, 2014 | | 2014 |
| Discovery and characterization of a G protein‐biased agonist of the D2 dopamine receptor (662.7) L Chun, R Free, A Moritz, J Conroy, J Meade, J Xiao, A Dulcey, ... The FASEB Journal 28, 662.7, 2014 | | 2014 |
| Erratum to: Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of" bath salts," produce opposite effects at the human dopamine transporter K Cameron, R Kolanos, R Vekariya, L De Felice, RA Glennon Psychopharmacology 227 (3), 501, 2013 | | 2013 |
